$RNG

Here are the stocks reporting next week that have a history of earnings beats and big share gains

Seven companies with strong earnings-beat histories report next week. RingCentral (up 160% YTD) has beaten estimates 98% of the time, averaging 4.2% gains on earnings days. Intuitive Surgical (down 26% YTD) has beaten estimates 89% of the time, averaging 2.4% gains. Both report earnings in October.

Original reporting
Published Oct 15, 2026, 5:50 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 15, 2026, 6:19 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Here are the stocks reporting next week that have a history of earnings beats and big share gains — source image
Decision brief

The 30-second read

$RNGBullishLow
01

Why it matters

This is a trading-calendar and pattern-recognition piece. It can help position for event-driven volatility, but it does not disclose new earnings results or guidance changes.

02

Market read

Useful for identifying which tickers may see heightened attention around their earnings dates, especially RNG and ISRG with explicit report timing.

03

What to watch

The article does not provide consensus expectations, valuation context, or what specific KPIs could drive the next print, so traders may be missing the true drivers of post-earnings moves.

Relevance 4/10Novelty 3/10Timing: ahead of next week’s earnings calendar, with specific report dates for RNG (Oct. 22) and ISRG (Oct. 20)

Background

CNBC screened Bespoke data for companies reporting next week that beat EPS estimates at least 80% of the time and whose shares gained at least 1.5% on earnings days, producing seven names.

Company-level read

Ticker impact

$RNGBullishMedium confidence
Context

RingCentral is highlighted as having beaten EPS estimates 98% of the time and gained an average 4.2% on earnings days, with its Oct. 22 after-close report date noted.

Expected impact

Likely volatility around the Oct. 22 earnings release as traders weigh the stock’s strong beat-and-reaction history.

Evidence & confidence

The piece provides a specific earnings-date catalyst and quantified historical behavior, but it does not disclose new guidance, results, or a fresh company-specific development that would reset expectations.

$ISRGNeutralMedium confidence
Context

Intuitive Surgical is included for beating earnings 89% of the time and averaging a 2.4% earnings-day gain, with an Oct. 20 expected report date.

Expected impact

Potential downside risk if results or guidance disappoint, given the article’s mention of recent medical-device weakness tied to J&J MedTech.

Evidence & confidence

The article frames ISRG with historical beat/reaction stats and a near-term earnings calendar, but it does not provide new ISRG fundamentals or a fresh ISRG-specific catalyst.

$DECKNeutralLow confidence
Context

Deckers Outdoor is named among seven stocks screened for next-week earnings beats and positive average share moves on earnings days.

Expected impact

Limited directional edge; expect event-driven trading around its earnings date without a clear new catalyst from this article.

Evidence & confidence

The body does not provide Deckers’ report date, beat rate, or earnings-day move magnitude, so the actionable information for DECK is thin.

Market effects

Reinforces that traders may target earnings-event setups across tech, medtech, and consumer discretionary, but it does not introduce new sector fundamentals.

Primarily US-focused earnings scheduling, with no cross-market policy or macro shock described.

Limited, as the article is a US earnings preview with no global regulatory or supply-chain event.

Counterpoint

Historical beat-and-reaction rates can mean-revert; a screen may overfit past outcomes and underweight valuation, competitive dynamics, or guidance quality.

Key entities

  • RingCentral

    Cloud communications firm scheduled to report Q3 results after the close on Oct. 22; cited as the strongest historical performer in the screen.

  • Intuitive Surgical

    Robotic surgery company expected to report on Oct. 20; included for strong historical EPS beat frequency and earnings-day share gains.

  • Deckers Outdoor

    Consumer footwear company included among the screened names, but without additional company-specific metrics in the excerpt.

Related articles

$NKEMed

Nike’s Weak First Quarter Report Ripples Across Footwear Sector

Nike reported weaker-than-expected Q1 sales and announced layoffs, causing its shares to drop 6.6% to $32.84. Competitors like Adidas and Puma saw mixed reactions, while other footwear brands and retailers experienced varied share price movements. Retailers such as Academy Sports + Outdoors and Dick’s Sporting Goods saw gains.

$ISRGHighAI 8/10

Intuitive receives CE mark for da Vinci 5 cardiac procedures

Intuitive Surgical (ISRG) received CE mark approval for its da Vinci 5 system in cardiac procedures, including coronary artery bypasses and thoracoscopic cardiotomy. The company aims to expand its robotic-assisted cardiac surgery offerings in Europe, with a dedicated team and partnerships with select centers. ISRG previously received FDA clearance for cardiac use in January.

$ISRGHighAI 8/10

Intuitive Surgical Gains CE Mark for Cardiac Robotics

Intuitive Surgical received CE mark approval for its da Vinci surgical robot to perform cardiac procedures in adults, including minimally invasive coronary artery bypass. This approval allows Intuitive to compete with rivals Medtronic and Johnson & Johnson in the surgical robotics space. The company aims to expand its cardiac surgery offerings globally, following FDA clearance for cardiovascular procedures in January.

$DECKHighAI 8/10

Deckers Outdoor Stock: Is DECK Underperforming the Consumer Discretionary Sector?

Deckers Brands reported Q1 2027 revenue of $1.02B, up 5.7% YoY, with HOKA and UGG leading growth. EPS rose 1.1% to $0.94. The company raised full-year EPS guidance to $7.35-$7.50 and adjusted gross-margin outlook above 56.5%. Shares fell 6.1% post-earnings due to tariff concerns and margin outlook, but analysts maintain a 'Moderate Buy' rating with an average price target of $117.67, implying 46.1% upside.